Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Terumo cardiovascular systems (terumo cvs) has become aware of a remote possibility that terumo advanced perfusion system 1 could experience a spontaneous loss of power. terumo cvs is issuing this advisory because the user's manual for the terumo advanced perfusion system 1 does not provide user instruction for responding to such an event.